Gilead Sciences, Inc.

G.06
No items found.

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. For 20 years Gilead has been working to transform the treatment of liver diseases. In nonalcoholic steatohepatitis (NASH), Gilead is advancing our understanding of disease progression, its impact on patients and health systems and how it can be accurately diagnosed. We are also researching potential future therapies for the disease.